<DOC>
	<DOCNO>NCT00446186</DOCNO>
	<brief_summary>The clinical study evaluate efficacy safety MK0476 adult patient allergic rhinitis .</brief_summary>
	<brief_title>MK0476 Study Adult Patients With Allergic Rhinitis ( 0476-378 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Adult patient seasonal allergic rhinitis Patients nasal disease ( e.g. , nasal polyp , septonasal arcuation , hypertrophic rhinitis ) , upper respiratory infection , sinusitis , infectious rhinitis , ocular infection disease severe enough interfere assessment effectiveness Patients rhinitis medicamentosa , nonallergic rhinitis ( e.g. , vasomotor rhinitis , eosinophilia rhinitis ) Patient disease cardiovascular , hepatic , renal , hematologic system , severe disease</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>